Goldman Sachs’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Goldman Sachs’s Portfolio SNCE Stock Details SNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,442	Closed	-$69.9K	–	5964
2023 Q2	$69.9K	Buy	16,442 +6,366	+63%	+$36.1K	﹤0.01%	5416
2023 Q1	$56.7K	Buy	10,076 +9,498	+1,643%	+$72.2K	﹤0.01%	5532
2022 Q4	$4.8K	Sell	578 -241	-29%	-$4.72K	﹤0.01%	5816
2022 Q3	$26K	Buy	819 +176	+27%	+$6.53K	﹤0.01%	5892
2022 Q2	$26K	Sell	643 -2,972	-82%	-$217K	﹤0.01%	6140
2022 Q1	$387K	Buy	3,615 +1,992	+123%	+$312K	﹤0.01%	5499
2021 Q4	$405K	Buy	+1,623	New	+$360K	﹤0.01%	5506

Other funds holding SNCE

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

GCM

Glynn Capital Management Menlo Park, California $209M AUM 31.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

Goldman Sachs's SNCE Position: Q3 2023 in Review

Goldman Sachs sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q3 2023, closing a stake of 16,442 shares — an estimated $69.9K sold.

Goldman Sachs first reported a position in SNCE in Q4 2021 and held it in 7 quarters. The position peaked at $405K in Q4 2021. 43 funds tracked by Wall St. Rank hold SNCE as of Q3 2023.

Goldman Sachs reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Goldman Sachs sold 16,442 Science 37 Holdings, Inc. Common Stock shares in Q3 2023, an estimated $69.9K.
Goldman Sachs first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Goldman Sachs's Science 37 Holdings, Inc. Common Stock position peaked at $405K in Q4 2021.
43 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q3 2023.

Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.